Vanguard Personalized Indexing Management
INDV icon

Vanguard Personalized Indexing Management’s Indivior Pharmaceuticals INDV Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$476K Buy
11,590
+2,720
+31% +$98.7K ﹤0.01% 1430
2026
Q1 		$270K Buy
8,870
+896
+11% +$29.6K ﹤0.01% 1665
2025
Q4 		$286K Buy
+7,974
New +$243K ﹤0.01% 1548
2025
Q1 		– Sell
-14,825
Closed -$184K – 1881
2024
Q4 		$184K Buy
+14,825
New +$153K ﹤0.01% 1539

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Personalized Indexing Management's INDV Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Indivior Pharmaceuticals (INDV) stake by 31% in Q2 2026, buying an estimated $98.7K and bringing the position to 11,590 shares worth $476K. The position accounts for ﹤0.01% of the portfolio, ranked #1430.

Vanguard Personalized Indexing Management first reported a position in INDV in Q4 2024 and has held it in 4 quarters since. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Vanguard Personalized Indexing Management held 11,590 shares of Indivior Pharmaceuticals worth $476K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 2,720 Indivior Pharmaceuticals shares in Q2 2026, an estimated $98.7K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1430 holding.
  • Vanguard Personalized Indexing Management first reported a position in Indivior Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • 336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.